A 5-year multicenter retrospective study on Motiva Ergonomix® breast implants: Minimizing complications and maximizing results.

Background: The task of promoting patient safety and aesthetically pleasing results, without exceeding anatomical limitations or compromising surgical outcomes, is one of the biggest challenges plastic surgeons face today. Methods: This is a multicenter, single-surgeon retrospective study evaluating the long-term safety and aesthetic results of Motiva Ergonomix® implants in 325 consecutive female recipients undergoing bilateral primary breast augmentation procedures, predominantly performed with a minimal incision approach between 2 and 3.5 cm. As a secondary benefit of the study, we aim to provide insight into modern patient needs and desires expressed during the pre-operative implant selection process, and data collected evaluating patient satisfaction rates using a pre-operative and post-operative Breast-Q questionnaire and a Patient and Observer Scar Assessment Scale (POSAS). Results: Between 2015 and 2019, six hundred and fifty Ergonomix® implants were implanted into 325 consecutive patients undergoing primary breast augmentation with a mean minimal incision length of 2.9 cm (range 2–3.5 cm). The mean follow-up time was 14 months with a range of 6 to 48 months. Over the 5 years, a total of 7 complications were reported among 325 patients with an overall complication rate of 2.15% and an overall reoperation rate of 1.23% (N = 2). Conclusions: Ergonomix® implants can provide a favorable choice for balancing both safety and aesthetics in primary breast augmentation procedures. Level of evidence: III, Risk/Prognostic Study [ABSTRACT FROM AUTHOR]